drugset / Trial / NCT00315276

Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD

NCT00315276

Phase 2 Completed 370 enrolled Cephalon
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the efficacy and safety of modafinil administered once daily for 9 weeks at doses of 255, 340, 425, and 510 mg as treatment for adults with ADHD.

Timeline

Start
2006-05
Primary completion
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Modafinil Small molecule 255 mg
Subject Modafinil Small molecule 340 mg
Subject Modafinil Small molecule 425 mg
Subject Modafinil Small molecule 510 mg